美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi NVO 2x Daily ETF

19.01

+0.38532.07%

成交量：15

成交額：284

市值：28.51萬

市盈率：- -

高：19.01

開：18.62

低：19.01

收：18.62

52周最高：27.19

52周最低：18.62

股本：1.50萬

流通股本：1.50萬

量比：0.48

換手率：0.10%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

焦點-打鼾、地鐵和隱形廣告：大型製藥公司如何瞄準中國人的腰圍

韓國上半年查獲非法進口減重藥物為去年全年三倍

韓國上半年查獲非法進口減重藥物為去年全年三倍

环球市场播报

韓國上半年查獲非法進口減重藥物為去年全年三倍

減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？

30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨

Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升

韓國加強單一股票槓桿ETF監管產品成交量縮水至十分之一

美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥

國產藥加速追趕減重明星賽道進入「群雄逐鹿」時代

韓國收緊單一股票槓桿監管後大量投資者轉投美國槓桿ETF

环球市场播报

韓國收緊單一股票槓桿監管後大量投資者轉投美國槓桿ETF

安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發

环球市场播报

Tradr ETFs推出兩隻掛鈎SK海力士（SKHY）單一股票槓桿

減肥藥重走PD-1老路，「白菜價藥王」要來？

韓國金融委員會提前落地單一股票槓桿 ETF 監管新規

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/NVOC/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","market":"US","secType":"STK","nameCN":"Corgi NVO 2x Daily ETF","latestPrice":19.0092,"timestamp":1789416000000,"preClose":18.6239,"halted":0,"volume":15,"delay":0,"changeRate":0.020688470191528138,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"盤前交易","change":0.3853,"latestTime":"09-15 06:26:37 EDT","open":18.6239,"high":19.0092,"low":19.0092,"amount":284,"amplitude":0,"askPrice":30.22,"askSize":100,"bidPrice":16.69,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"listingDate":1784001600000,"exchange":"CBOE","adjPreClose":19.0092,"nav":18.66,"aum":279900,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":18.6239,"preClose":19.0092,"latestTime":"16:10 EDT","volume":4,"amount":76.0368,"timestamp":1789416603976,"change":-0.3853,"changeRate":-0.020269,"amplitude":0},"volumeRatio":0.4807692307692308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4807692307692308,"shares":15000,"dividePrice":0,"high":19.0092,"amplitude":0,"preClose":18.6239,"low":19.0092,"week52Low":18.6239,"pbRate":"--","week52High":27.1863,"institutionHeld":0,"latestPrice":19.0092,"eps":0,"divideRate":0,"volume":15,"delay":0,"ttmEps":0,"open":18.6239,"prevYearClose":24.92,"prevWeekClose":18.6239,"prevMonthClose":20.8451,"prevQuarterClose":24.92,"fiveDayClose":21.8898,"twentyDayClose":21.1046},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOC\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661228461","title":"焦點-打鼾、地鐵和隱形廣告：大型製藥公司如何瞄準中國人的腰圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228461","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228461?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 13:15","pubTimestamp":1787548554,"startTime":"0","endTime":"0","summary":"中国不允许制药公司直接向消费者宣传处方药。临床试验表明，礼来的GLP-1药物Mounjaro可缓解该病症。这家制药公司致力于使其公共传播中的语言更通俗易懂。医疗和法律专家指出，某些体重管理宣传活动也可能越界成为药物广告。礼来公司在声明中表示，其教育活动并未推广任何特定药品，且与中国的健康战略“保持一致”。辉瑞、创新药业、美团以及中国市场监管部门均拒绝或未回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4S44L0C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","IE00B1BXHZ80.USD","LU1868837300.USD","RXL","SGXZ99366536.SGD","LU2236285917.USD","LU2023250330.USD","LU2468319806.SGD","LU0354030438.USD","LU1035775433.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU1868836757.USD","LU2360106947.USD","SG9999015952.SGD","LU1093756168.USD","LU2471134952.CNY","LU2028103732.USD","LU2097828474.EUR","LU0786609619.USD","LU2552382132.HKD","LU0385154629.USD","LU0456855351.SGD","LU1551013425.SGD","LU2023250504.SGD","LU0321505868.SGD","LU2491050154.USD","BK1583","LU2746668974.SGD","OZEM","IE00BKDWB100.SGD","LU1127390331.HKD","LU1979441026.SGD","LU0320765059.SGD","LU0882574055.USD","LU0943347566.SGD","SG9999013999.USD","LU0345770993.USD","LU1061106388.HKD","LU0471298777.SGD","LU2106854487.HKD","LU0463099449.HKD","BK4516","LU2097828714.EUR","LU0158827781.USD","IE00BLSP4239.USD","LU0353189680.USD","SG9999015945.SGD","01801","LU0225283273.USD","LU0672654240.SGD","LU0882574139.USD","LU1868837136.USD","LU1894683264.USD","IE00BJT1NW94.SGD","TMED","LU2456880835.USD","IE00BFTCPJ56.SGD","LU0683600562.USD","LU1969619763.USD","IE0004445239.USD","LU0964807845.USD","LU2213496289.HKD","LU2237438978.USD","LU2596442595.SGD","ELIL","SG9999001176.USD","IE00B775H168.HKD","TRUH","SG9999015986.USD","LU2750360997.AUD","LU0170899867.USD","SG9999018857.SGD","IE00BK4W5L77.USD","LU1064131342.USD","BK4588","IE00BJLML261.HKD","LU0889565916.HKD","LU2112291526.USD","SGXZ51526630.SGD","LU0109394709.USD","LU0234572021.USD","IE00BLSP4452.SGD","LU1623119135.USD","LU0006306889.USD","LU2089984988.USD","LU1188198961.HKD","LU2237443549.SGD","SG9999015978.USD","SG9999014880.SGD","HK0000165453.HKD","LU2168564149.EUR","LU2211815571.USD","ELIS","MHIP","LU1066053197.SGD","LU0820561909.HKD","BK4585","IE00BJJMRY28.SGD","LU2097828631.EUR","LU2756315318.SGD","PFE","LU0502904849.HKD","LU2168564065.EUR","BK4533","LU2491049909.HKD","LU0823416689.USD","LU0689472784.USD","LU0306806265.USD","LU1548497426.USD","LU0133085943.USD","LU0455707207.USD","FHLC","LU2264538146.SGD","LU1280957306.USD","SG9999011175.SGD","LU2265009873.SGD","BK1161","LU2602419157.SGD","LU0114720955.EUR","IE0002270589.USD","LU1551013342.USD","PJP","SG9999001176.SGD","SG9999014914.USD","LU2417539215.USD","LU0256863811.USD","LU2896262040.SGD","LLYZ","LU0354030511.USD","LU0823434740.USD","MEDI","LU0198837287.USD","SG9999002232.USD","LU2237443622.USD","IE00BKPKM429.USD","LU0985481810.HKD","IE00BZ1G4Q59.USD","LU2089284900.SGD","LU2552382215.SGD","LLII","IE00B7KXQ091.USD","LU0203202063.USD","LU1868836914.USD","LU1989771016.USD","VHT","IE00B4JS1V06.HKD","IE0001KFT4U8.USD","GDOC","LU0321505439.SGD","IE000M9KFDE8.USD","LU2361044865.SGD","SGXZ81514606.USD","LU2552382058.USD","LU0061475181.USD","MEDX","BK4550","LU0203201768.USD","LU2324357040.USD","LU2168563687.JPY","XLV","LU2328871848.SGD","LU0174119429.USD","LU1720051017.SGD","LU2063271972.USD","LU0238689110.USD","LU2746668461.USD","BK4532","IE00B19Z3581.USD","LU0345770308.USD","NVOX","LU0823434583.USD","KURE","LU1145028129.USD","LU0323591593.USD","LU2242644610.SGD","LU2462591350.SGD","LU0058720904.USD","IE00BN29S564.USD","IE00BBT3K403.USD","LLY","WDNA","SG9999017495.SGD","LU0708995401.HKD","LU0432979614.USD","LU0096364046.USD","IE00B2B36J28.USD","LU2271345857.HKD","LU0289739699.SGD","LU2237443895.HKD","FTXH","THNR","LU1629891620.HKD","IE00BFSS8Q28.SGD","LU2462157665.USD","LU0471298694.HKD","NVOH","LU1069344957.HKD","LU1814569148.SGD","LU0244354667.USD","LU0306807586.USD","LU1366192091.USD","SG9999014906.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","IE00B3T34201.USD","PPH","LU0079474960.USD","LU1988902786.USD","IE0005OL40V9.USD","LU2237443978.SGD","LU0097036916.USD","LU1868836591.USD","LU0225771236.USD","LU0210536198.USD","LU1804176565.USD","SGXZ31699556.SGD","LU1093756325.SGD","BK4599","LU2097828557.USD","LU0640476718.USD","LU2237443382.USD","LU1917777945.USD","BK4568","LLYX","BK1589","LU1712237335.SGD","LU2108987350.USD","IE0004445015.USD","LU0158827948.USD","SG9999002224.SGD","LU1023059063.AUD","LU0106261372.USD","LU0122379950.USD","LU1057294990.SGD","BK4007","LU2361044949.HKD","LU0353189763.USD","LU1323610961.USD","IHE","HRTS","IE00BJJMRZ35.SGD","IYH","LU0094547139.USD","LU1232071149.USD","LU0820561818.USD","LU1983299246.USD","ILDR","LU2491050071.SGD","LU1974910355.USD","IE00BWXC8680.SGD","SG9999003800.SGD","JDOC","LU2361045086.USD","IE00B1XK9C88.USD","SG9999018865.SGD","CURE","LU0109391861.USD","LU2087625088.SGD","AGNG","IE0009355771.USD","LU1894683348.USD","LU0466842654.USD","BK4534","LU2168564222.USD","IE00B19Z3B42.SGD","LU2488822045.USD","LU2756315664.SGD","IXJ","LU1720051108.HKD","SGXZ57979304.SGD","LU2168564495.EUR","LU2471134879.HKD","LU1691799644.USD","IE00B4R5TH58.HKD","LU2471134523.USD","LU2471134796.USD","LU2111349929.HKD","LU1066051498.USD","LU2097828805.USD","LU2461242641.AUD","LU2750360641.GBP","IE00BKVL7J92.USD","LU0225284248.USD","LU2089283258.USD","LU0320765992.SGD","GB00BDT5M118.USD","IE0002141913.USD","LU2237443465.HKD","BK4581","NVOC","LU0154236417.USD","LU1267930730.SGD","CANC","LU0820562030.AUD","LU1883839398.USD","LU0316494557.USD","SG9999014898.SGD","LU1291159041.SGD","LU0417517546.SGD","LU2023251221.USD","BK4592","LU0326950275.SGD","LU0266013472.USD","IE00BFSS7M15.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661421362","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661421362","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661421362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:04","pubTimestamp":1787537094,"startTime":"0","endTime":"0","summary":"来源：环球市场播报韩国海关周一公布的数据显示，上半年从境外非法进口Wegovy、Mounjaro等减重药物的查获案件数量是2025年全年查获量的三倍以上。韩国关税厅统计数据显示，16月，海关共查获4155起通过海淘直购及其他非法渠道走私Wegovy、Mounjaro的案件，远高于2025年全年的1189起。非法进口大多通过国际邮件渠道：越来越多韩国民众从海外线上商城购买这类减重药物，再通过国际快递寄回国内。另有656起案件为旅客个人携带入境，高于去年全年的134起。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/08/24100458213801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["OZEM","NVOX","NVOC","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661504242","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661504242","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661504242?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:01","pubTimestamp":1787536889,"startTime":"0","endTime":"0","summary":"韩国海关周一公布的数据显示，上半年从境外非法进口Wegovy、Mounjaro等减重药物的查获案件数量是2025年全年查获量的三倍以上。　　韩国关税厅统计数据显示，16月，海关共查获4155起通过海淘直购及其他非法渠道走私Wegovy、Mounjaro的案件，远高于2025年全年的1189起。　　非法进口大多通过国际邮件渠道：越来越多韩国民众从海外线上商城购买这类减重药物，再通过国际快递寄回国内。　　韩国禁止旅客随身携带Wegovy与Mounjaro入境。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-24/doc-inipkrka2981063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVOH","OZEM","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661242360","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661242360","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661242360?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 09:59","pubTimestamp":1787536781,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","NVOC","OZEM","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IYH","CURE","NVOC","THNR","PJP","FHLC","FXH","XLVI","MEDI","TRUH","RSPH","PINK","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["CURE","BK4590","PJP","RSPH","THNR","BK4144","PINK","MEDI","NBDS","XLVI","IYH","TRUH","FXH","JDOC","NVOC","GLP","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969925?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDI","IYH","XLVI","THNR","PJP","FHLC","RSPH","FXH","PINK","CURE","NBDS","NVOC","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644961","title":"韓國加強單一股票槓桿ETF監管 產品成交量縮水至十分之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644961","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644961?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 22:26","pubTimestamp":1786112818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MUZ","MUD","MIC","AXTX","MUYY","ADVX","MUU","NVOC","MULL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657896386?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["THNR","LU0053666078.USD","LLYX","UYG","IE00B19Z3B42.SGD","BK4590","LU0211331839.USD","BAC","FTXO","LU0314106906.USD","GLP","IE0001KFT4U8.USD","KBWB","LU1506573853.SGD","BK4534","IE00BZ1G4Q59.USD","ELIS","FXH","LU0980610538.SGD","LLII","LLYZ","PJP","MEDI","IYF","LU0170899867.USD","RSPH","TFNS","JDOC","OZEM","LU0130103400.USD","XLVI","FHLC","VFH","NBDS","XLF","IYG","PGF","CURE","IYH","TRUH","LU1496350171.SGD","BK4588","ELIL","FNCL","LU0106831901.USD","IE00BBT3K403.USD","LU0648001328.SGD","PINK","LU1280957306.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547441","title":"國產藥加速追趕 減重明星賽道進入「群雄逐鹿」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547441","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935232,"startTime":"0","endTime":"0","summary":"新华财经上海8月5日电2026年，我国“体重管理年”三年行动进入收官之年。当前，全民体重管理意识和技能显著提升，健康生活方式更加普及，部分人群体重异常状况得到改善。体重管理催生了减重经济。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832808212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832808212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOX","RSPH","NVOC","MEDI","NVOH","THNR","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519388","title":"韓國收緊單一股票槓桿監管後 大量投資者轉投美國槓桿ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519388","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519388?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:39","pubTimestamp":1785915540,"startTime":"0","endTime":"0","summary":"韩国政府加强对单一股票杠杆交易所交易基金的投资监管后，韩国投资者资金正在快速转向美国杠杆ETF。崇实大学会计学系教授孙在成表示：“此次监管虽然是为了保护投资者，但由于是在损失已经发生后出台，因此具有较强的事后补救性质。韩国单一股票杠杆ETF波动性过高，而美国市场相对稳定，因此投资者转向海外杠杆ETF是自然现象。”","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimhawf5184114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AVGG","AXTX","NVOC","AVGX","AVL","MUYY","MIC","MUZ","MULL","MGKX","MUD","AVS","UCC","AVGW","QTOC","EO","MUU","UMDD","AVGU","QNTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657845519","title":"韓國收緊單一股票槓桿監管後 大量投資者轉投美國槓桿ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2657845519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657845519?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:34","pubTimestamp":1785915262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MGKX","MIC","MUYY","MULL","UMDD","AVS","AVL","AXTX","AVGU","AVGG","QNTU","AVGX","AVGW","EO","MUD","MUU","NVOC","QTOC","UCC","MUZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657674945?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"fut","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4566","LU0320765992.SGD","IE00BJT1NW94.SGD","NBDS","PINK","IE00BFTCPJ56.SGD","BK4534","RSPH","NVOC","IBBQ","LU0109394709.USD","LU0058720904.USD","PBE","LU0889565916.HKD","LU0122379950.USD","LU2089984988.USD","BBH","LU0289739699.SGD","BK4581","IE0009355771.USD","LU1983299246.USD","IBB","LU1061106388.HKD","BK4139","TRUH","CURE","IE00B4R5TH58.HKD","MEDI","PJP","LU1571399168.USD","LU2242646821.SGD","THNR","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU2468319806.SGD","FXH","IYH","LU0868494617.USD","BK4533","IE00B2B36J28.USD","BK4588","LU2242652126.USD","SG9999001440.SGD","BK4599","TBXU","IE0002141913.USD","FHLC","XLVI","AMGN","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004625","title":"Tradr ETFs推出兩隻掛鈎SK海力士（SKHY）單一股票槓桿","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004625?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 20:13","pubTimestamp":1785240799,"startTime":"0","endTime":"0","summary":"金吾财讯 | ETF发行商Tradr ETFs推出两只单一股票杠杆ETF，提供针对SK海力士（SKHY）的双向杠杆交易工具，基金将于CBOE交易所上市交易。两只产品分别为 Tradr 2X Short SK hynix Daily ETF（SKHA）以及Tradr 2X Long SK hynix Daily ETF（SKHN）。Tradr ETFs产品与资本市场负责人Matt Markiewicz表示，借助SKHA与SKHN，交易者可通过ETF工具表达对SK海力士及存储器行业周期看涨、看空观点，无需开立保证金账户或交易期权。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUD","MULL","BK4112","EEMO","SKDD","07709","BK4585","HYNX","BK4532","MUU","BCDF","BK4141","SKUU","AXTX","RAM","EDZ","SK","BK4588","SKHYV","MUZ","SKHZ","NVOC","CBOE","DRAL","MIC","SKHY","MUYY","SKHU","SKHX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653874827","title":"減肥藥重走PD-1老路，「白菜價藥王」要來？","url":"https://stock-news.laohu8.com/highlight/detail?id=2653874827","media":"健康凯歌","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653874827?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 09:23","pubTimestamp":1784683395,"startTime":"0","endTime":"0","summary":"一场减重大战，即将来临。走GCG/GLP-1双靶点路线的玛仕度肽，9毫克组60周减掉了18.55%。研究显示，80周最高剂量组减重28.3%，BMI≥35的对照组，104周减重甚至到了30.3%。此外，医保几轮谈判下来，PD-1的年治疗费用已经不要3万元，这已经不能单纯的算是降价了。疗效类似，再牛的“药王”也扛不住降价的仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8uwIsXpkDir","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["NBDS","THNR","LU1169590202.USD","PD","NVOC","FXH","XLVI","IYH","BK4023","LU1169589451.USD","PINK","PJP","TRUH","FHLC","MEDI","CURE","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653227932","title":"韓國金融委員會提前落地單一股票槓桿 ETF 監管新規","url":"https://stock-news.laohu8.com/highlight/detail?id=2653227932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653227932?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 16:18","pubTimestamp":1784621901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AXTX","MUYY","BK4550","MUU","MIC","MULL","BK4588","BK4585","NVOC","MUZ","MUD","FDN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}